Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
Endocrine Connections|September 18, 2013
Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumorsR C S van Adrichem, L J Hofland, R A Feelders, et al.
Endocrinology|October 31, 2013
β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegalyFederico Gatto, Richard Feelders, Rob van der Pas, et al.
Endocrine-Related Cancer|May 30, 2008
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center studyTullio Florio, Federica Barbieri, Renato Spaziante, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2012
Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegalyFederico Gatto, Richard A Feelders, Rob van der Pas, et al.
Endocrine-Related Cancer|June 4, 2014
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumorsMaria Cristina De Martino, Richard A Feelders, Wouter W de Herder, et al.
The Journal of Clinical Endocrinology and Metabolism|August 17, 2006
Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growthPeter M van Koetsveld, Giovanni Vitale, Wouter W de Herder, et al.
BMC Cancer|April 7, 2019
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfallsCarolien M Beukhof, Tessa Brabander, Francien H van Nederveen, et al.
Endocrine|March 7, 2019
IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancerMaria Cristina De Martino, Peter M van Koetsveld, Richard A Feelders, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegalyS J C M M Neggers, S E Franck, F W M de Rooij, et al.
Endocrine-Related Cancer|August 19, 2016
Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomasS G Creemers, P M van Koetsveld, F J van Kemenade, et al.
Pageof 35